D-chiro-Inositol

DB15350InvestigationalSmall molecule

D-chiro-Inositol is under investigation in clinical trial NCT03201601 (Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome).

Mechanism: Pharmacologically active on Aromatase
Curator reviewed
Formula / weight: C₆H₁₂O₆ · 180.1559 g/mol (avg)
Also known as: D-Inositol

Resolves to

Compound

UNII6R79WV4R10CAS643-12-9ChEMBLCHEMBL3976780ChEBI27374

Clinical / RWD

RxNorm2267019

Structure

InChIKeyCDAISMWEOUEBRE-SHFUYGGZSA-NSMILESO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O

Targets

P11511CYP19A1

Transporters

Q8WWX8SLC5A11

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with D-chiro-Inositol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account